MBX Biosciences (MBX) Share-based Compensation (2023 - 2026)
MBX Biosciences' Share-based Compensation came in at $6.06 million for Q2 2026, up 213.1% from $1.94 million a year earlier and up 10.6% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, MBX Biosciences reported Share-based Compensation of $16.45 million, up 154.8% year-over-year; for FY2025, it came in at $8.68 million, up 66.2% from FY2024.
- Going back by year, Share-based Compensation was $5.22 million in FY2024 (+155.6%) and $2.04 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q4 2023.
- Year-over-year, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 106.9% over the last seven quarters.
- Business Quant data shows MBX's Share-based Compensation at $5.48 million (Q1 2026), $2.66 million (Q4 2025) and $2.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | MBX Biosciences | 2.41 Bn | 785.21 Mn | - | 6.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.06 Mn |
| Mar 31, 2026 | 5.48 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 919,000.00 |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 1.02 Mn |
API Access
MBX Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();